Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of the American Chemical Society
|
March 22, 2021
Selective CRAF Inhibition Elicits Transactivation
Charles W Morgan, Ian L Dale, Andrew P Thomas, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 25, 2014
Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes
Amy Pointon, Alexander R Harmer, Ian L Dale, et al.
Assay and Drug Development Technologies
|
October 12, 2018
A Comparative Study of Fluorescence Assays in Screening for BRD4
Pia Hansson, Helen Boyd, Ian L Dale, et al.
Communications Biology
|
November 10, 2021
Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
Francesca Malvezzi, Christopher J Stubbs, Thomas A Jowitt, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET
Gavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
Molecular Pharmacology
|
November 3, 2016
Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics
J Daniel Hothersall, Dong Guo, Sunil Sarda, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2022
Discovery of a selective c-MET inhibitor with a novel binding mode
Gavin W Collie, Louise Barlind, Sana Bazzaz, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors
Gavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.
Journal of Medicinal Chemistry
|
May 15, 2024
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches
Luca Carlino, Peter C Astles, Bryony Ackroyd, et al.
Journal of Medicinal Chemistry
|
February 8, 2022
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
Jon J Winter-Holt, Catherine Bardelle, Elisabetta Chiarparin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of the American Chemical Society
|
March 22, 2021
Selective CRAF Inhibition Elicits Transactivation
Charles W Morgan, Ian L Dale, Andrew P Thomas, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 25, 2014
Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes
Amy Pointon, Alexander R Harmer, Ian L Dale, et al.
Assay and Drug Development Technologies
|
October 12, 2018
A Comparative Study of Fluorescence Assays in Screening for BRD4
Pia Hansson, Helen Boyd, Ian L Dale, et al.
Communications Biology
|
November 10, 2021
Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
Francesca Malvezzi, Christopher J Stubbs, Thomas A Jowitt, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET
Gavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
Molecular Pharmacology
|
November 3, 2016
Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics
J Daniel Hothersall, Dong Guo, Sunil Sarda, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2022
Discovery of a selective c-MET inhibitor with a novel binding mode
Gavin W Collie, Louise Barlind, Sana Bazzaz, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors
Gavin W Collie, Cheryl M Koh, Daniel J O'Neill, et al.
Journal of Medicinal Chemistry
|
May 15, 2024
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches
Luca Carlino, Peter C Astles, Bryony Ackroyd, et al.
Journal of Medicinal Chemistry
|
February 8, 2022
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
Jon J Winter-Holt, Catherine Bardelle, Elisabetta Chiarparin, et al.
Page
of 2